pitfalls and progress in the development of immune stimulatory nucleic acids
Published 2 years ago • 1K plays • Length 1:01:51Download video MP4
Download video MP3
Similar videos
-
33:21
chemistry of therapeutic oligonucleotides: a brief overview
-
54:11
shalini andersson: developing oligonucleotides into therapies
-
23:23
oligonucleotides as a new therapeutic class: progress report & prescription
-
1:02:27
john chaput | a nucleic acid approach to antibody therapeutics
-
9:25
what are oligonucleotide therapeutics, and how do they work?
-
1:02:53
art krieg: how to test for immune activation by your therapeutic oligonucleotide
-
1:02:45
nucleic acid therapeutics: successes, milestones, and upcoming innovation
-
57:45
art krieg: introduction to nucleic acid immunity & implications for optimizing cancer immunotherapy
-
59:20
anastasia khvorova: rnai-based therapeutics: 2018 outlook
-
25:00
oligonucleotide therapeutic development: pre-clinical and translational considerations
-
6:54
developing next-generation oligonucleotide therapeutics
-
13:49
oligonucleotide therapeutics: new drugs that could stop covid-19
-
18:43
oligo meeting 2017 - immune stimulatory oligos
-
12:19
oligonucleotide-based therapeutics - creative biolabs
-
1:01:28
chemical and nanotechnology based approaches to build next gen oligonucleotide therapeutics
-
2:03
our impact: innovation in nucleic acid therapies
-
22:47
chemistry of oligonucleotide therapeutics 101
-
4:03
oem manufacturing capabilities for nucleic acid synthesis